BioAffinity Technologies EBIT Margin 2022-2025 | BIAF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

BioAffinity Technologies ebit margin from 2022 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues

BioAffinity Technologies EBIT Margin 2022-2025 | BIAF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

BioAffinity Technologies ebit margin from 2022 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues

Related Stocks
Company Name	Market Cap
AstraZeneca (AZN)	$229.7B
Amgen (AMGN)	$153.5B
Gilead Sciences (GILD)	$149.5B
Vertex Pharmaceuticals (VRTX)	$96B
Bristol Myers Squibb (BMY)	$93.5B
CSL (CSLLY)	$83.2B
GSK (GSK)	$76.9B
Regeneron Pharmaceuticals (REGN)	$57.9B
Alnylam Pharmaceuticals (ALNY)	$57B
Argenex SE (ARGX)	$39.1B
BioNTech SE (BNTX)	$26.3B
Insmed (INSM)	$23.9B
Royalty Pharma (RPRX)	$20.3B
Biogen (BIIB)	$18.8B
Incyte (INCY)	$15.5B
Illumina (ILMN)	$14.6B
Genmab (GNMSF)	$14.3B
Genmab (GMAB)	$13.5B
Ascendis Pharma (ASND)	$12B
BioMarin Pharmaceutical (BMRN)	$10.9B
QIAGEN (QGEN)	$10.7B
Swedish Orphan Biovitrum (BIOVF)	$10.6B
Exelixis (EXEL)	$10.1B
Moderna (MRNA)	$9.9B
Verona Pharma American Depositary Share (VRNA)	$9B
Blueprint Medicines (BPMC)	$8.3B
Bio-Techne Corp (TECH)	$7.9B
Halozyme Therapeutics (HALO)	$7.7B
Exact Sciences (EXAS)	$7.7B
Roivant Sciences (ROIV)	$7.6B